BELTON, Texas, Nov. 12, 2025 /PRNewswire/ — Armor Health (ArmorHealthcare.com), a leading national provider of integrated…
Category: News
STRETCH ZONE OPENS NEWEST LOCATION IN MAPLE GROVE, MN
New wellness studio helps residents move better, feel better, and live better—one stretch at a time…
Solano County Employees Get Strike-Ready After Several Weeks of Stalled Contract Negotiations with County Administration
On November 13, hundreds of County workers who have signed a strike pledge, will learn what…
Survey Reveals Majority of New England Families Seek Senior Care Only in a Crisis
Aging Life Care Association® New England Chapter Uncovers Trends, Gaps in Elder Care BOSTON, Nov. 12,…
27 miembros de la facultad de YSM reconocidos por investigaciones altamente citadas
NEW HAVEN, Connecticut, 12 de noviembre de 2025 /PRNewswire-HISPANIC PR WIRE/ — Veintisiete miembros del cuerpo…
Boehringer awarded FDA Commissioner’s National Priority Voucher for HERNEXEOS® in HER2 lung cancer
RIDGEFIELD, Conn., Nov. 7, 2025 /PRNewswire/ — The U.S. Food & Drug Administration (FDA) has awarded…
Chronic Kidney Disease Is Now the Ninth Leading Cause of Death
NEW YORK and HOUSTON, Nov. 7, 2025 /PRNewswire/ — Record numbers of men and women globally…
eBook: Setting up for coordination of benefits (COB) success
A robust coordination of benefits (COB) program can be one of the most difficult elements for…
U.S. FDA approves KYGEVVI™ (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)
Approved indication:KYGEVVI™ (doxecitine and doxribtimine) powder for oral solution (2g/2g) is approved for the treatment of…
AusperBio Announces Late-Breaking 48-Week Phase II Data of AHB-137 in Chronic Hepatitis B at AASLD 2025
Pooled 48-week results from two Phase II studies show sustained antiviral responses and a favorable safety…